Showing results (71-80 of 123) with videos related to
Sort By:
Pageof 13
AIDS (London, England)|July 23, 2020
No HIV-1 molecular evolution on long-term antiretroviral therapy initiated during primary HIV-1 infectionBasma Abdi, Thuy Nguyen, Sophie Brouillet, et al.The Journal of Infectious Diseases|January 15, 2011
A therapeutic dendritic cell-based vaccine for HIV-1 infectionFelipe García, Núria Climent, Lambert Assoumou, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|May 22, 2007
Prevalence of HIV-1 drug resistance in treated patients: a French nationwide studyDominique Costagliola, Diane Descamps, Lambert Assoumou, et al.Antimicrobial Agents and Chemotherapy|August 19, 2015
Emtricitabine seminal plasma and blood plasma population pharmacokinetics in HIV-infected men in the EVARIST ANRS-EP 49 studyElodie Valade, Jean-Marc Tréluyer, Silvia M Illamola, et al.The Journal of Antimicrobial Chemotherapy|February 14, 2013
Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL in 2009: a French nationwide studyLambert Assoumou, Diane Descamps, Sabine Yerly, et al.Pharmacotherapy|March 1, 2019
Lack of a Clinically Significant Pharmacokinetic Interaction between Etravirine and Raltegravir Using an Original Approach Based on Drug Metabolism, Protein Binding, and Penetration in Seminal Fluid: A Pharmacokinetic Substudy of the ANRS-163 ETRAL StudyMinh Patrick Lê, Marc-Antoine Valantin, Lambert Assoumou, et al.AIDS (London, England)|November 8, 2017
Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular riskJosé M Gatell, Lambert Assoumou, Graeme Moyle, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|May 21, 2019
Brief Report: Impact of ART Classes on the Increasing Risk of Cerebral Small-Vessel Disease in Middle-Aged, Well-Controlled, cART-Treated, HIV-Infected IndividualsEdouard Januel, Ophelia Godin, Antoine Moulignier, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 16, 2017
Silent Cerebral Small-Vessel Disease Is Twice as Prevalent in Middle-Aged Individuals With Well-Controlled, Combination Antiretroviral Therapy-Treated Human Immunodeficiency Virus (HIV) Than in HIV-Uninfected IndividualsAntoine Moulignier, Julien Savatovsky, Lambert Assoumou, et al.Open Forum Infectious Diseases|January 23, 2025
Engagement in Preexposure Prophylaxis Care at 1 Year Among Men Who Have Sex With Men Enrolled in the French ANRS PREVENIR Cohort StudyGeoffroy Liegeon, Lambert Assoumou, Lydie Béniguel, et al.Pageof 13